INVESTMENTS - RELATED PARTIES (Details 2) - USD ($)			12 Months Ended		24 Months Ended
	Dec. 17, 2020	Aug. 20, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Unrealized loss in common stock of Alzamend			$ (1,327,000)	$ 919,000
Investment in Alzamend common stock (in shares)				217,398
Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Investment in Alzamend common stock (in shares)	814,095	413,793			2,400,000
Alzamend [Member] | Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Begining balance (in shares)			428,000
Begining balance (in dollars per shares)			$ 1.50
Begining balance			$ 642,000
Purchase of shares from an Alzamend shareholder (in shares)			62,000
Purchase of shares from an Alzamend shareholder (in dollars per shares)			$ 0.81
Purchase of shares from an Alzamend shareholder			$ 50,000
Securities purchase agreement (in shares)			4,000,000
Securities purchase agreement (in dollars per shares)			$ 1.50
Securities purchase agreement			$ 6,000,000
Investment in Alzamend initial public offering (in sharers)			2,000,000
Investment in Alzamend initial public offering (in dollars per shares)			$ 5.00
Investment in Alzamend initial public offering			$ 10,000,000
Open market purchases after initial public offering (in shares)			457,000
Open market purchases after initial public offering (in dollars per shares)			$ 4.67
Open market purchases after initial public offering			$ 2,132,000
Unrealized loss in common stock of Alzamend			$ (5,625,000)
Investment in Alzamend common stock (in shares)			6,947,000
Investment in Alzamend common stock (in dollar per share)			$ 1.90
Investment in Alzamend common stock			$ 13,199,000
Investment in Alzamend options			$ 31,000
Ending balance (in shrares)			13,230,000	428,000	13,230,000